Literature DB >> 19686277

Colonization of residents and staff of a long-term-care facility and adjacent acute-care hospital geriatric unit by multiresistant bacteria.

A March1, R Aschbacher, H Dhanji, D M Livermore, A Böttcher, F Sleghel, S Maggi, M Noale, C Larcher, N Woodford.   

Abstract

Long-term-care facilities (LTCFs) are reservoirs of resistant bacteria. We undertook a point-prevalence survey and risk factor analysis for specific resistance types among residents and staff of a Bolzano LTCF and among geriatric unit patients in the associated acute-care hospital. Urine samples and rectal, inguinal, oropharyngeal and nasal swabs were plated on chromogenic agar; isolates were typed by pulsed-field gel electrophoresis; resistance genes and links to insertion sequences were sought by PCR; plasmids were analysed by PCR, restriction fragment length polymorphism and incompatibility grouping. Demographic data were collected. Of the LTCF residents, 74.8% were colonized with ≥1 resistant organism, 64% with extended-spectrum β-lactamase (ESBL) producers, 38.7% with methicillin-resistant Staphylococcus aureus (MRSA), 6.3% with metallo-β-lactamase (MBL) producers, and 2.7% with vancomycin-resistant enterococci. Corresponding rates for LTCF staff were 27.5%, 14.5%, 14.5%, 1.5% and 0%, respectively. Colonization frequencies for geriatric unit patients were lower than for those in the LTCF. Both clonal spread and plasmid transfer were implicated in the dissemination of MBL producers that harboured IncN plasmids bearing bla(VIM-1), qnrS, and bla(SHV-12). Most (44/45) ESBL-producing Escherichia coli isolates had bla(CTX-M) genes of group 1; a few had bla(CTX-M) genes of group 9 or bla(SHV-5); those with bla(CTX-M-15) or bla(SHV-5) were clonal. Risk factors for colonization of LTCF residents with resistant bacteria included age ≥86 years, antibiotic treatment in the previous 3 months, indwelling devices, chronic obstructive pulmonary disease, physical disability, and the particular LTCF unit; those for geriatric unit patients were age and dementia. In conclusion, ESBL-producing and MBL-producing Enterobacteriaceae and MRSA were prevalent among the LTCF residents and staff, but less so in the hospital geriatric unit. Education of LTCF employees and better infection control are proposed to minimize the spread of resistant bacteria in the facility.

Entities:  

Mesh:

Year:  2009        PMID: 19686277     DOI: 10.1111/j.1469-0691.2009.03024.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  61 in total

1.  Fecal carriage of carbapenemase-producing Enterobacteriaceae: a hidden reservoir in hospitalized and nonhospitalized patients.

Authors:  Desirèe Gijón; Tânia Curiao; Fernando Baquero; Teresa M Coque; Rafael Cantón
Journal:  J Clin Microbiol       Date:  2012-03-07       Impact factor: 5.948

2.  Outbreak analysis and typing of MRSA isolates by automated repetitive-sequence-based PCR in a region with multiple strain types causing epidemics.

Authors:  J J Hirvonen; T Pasanen; P Tissari; S Salmenlinna; J Vuopio; S-S Kaukoranta
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-05-27       Impact factor: 3.267

Review 3.  Bloodstream infections in older patients.

Authors:  Dafna Yahav; Noa Eliakim-Raz; Leonard Leibovici; Mical Paul
Journal:  Virulence       Date:  2015-12-18       Impact factor: 5.882

4.  High Prevalence of Multidrug-Resistant Organism Colonization in 28 Nursing Homes: An "Iceberg Effect".

Authors:  James A McKinnell; Loren G Miller; Raveena D Singh; Gabrielle Gussin; Ken Kleinman; Job Mendez; Bryn Laurner; Tabitha D Catuna; Lauren Heim; Raheeb Saavedra; James Felix; Crystal Torres; Justin Chang; Marlene Estevez; Joanna Mendez; Gregory Tchakalian; Leah Bloomfield; Sandra Ceja; Ryan Franco; Aaron Miner; Aura Hurtado; Ratharo Hean; Alex Varasteh; Philip A Robinson; Steven Park; Steven Tam; Thomas Tjoa; Jiayi He; Shalini Agrawal; Stacey Yamaguchi; Harold Custodio; Jenny Nguyen; Cassiana E Bittencourt; Kaye D Evans; Vincent Mor; Kevin McConeghy; Robert A Weinstein; Mary K Hayden; Nimalie D Stone; Karl Steinberg; Nancy Beecham; Jocelyn Montgomery; Walters DeAnn; Ellena M Peterson; Susan S Huang
Journal:  J Am Med Dir Assoc       Date:  2020-06-16       Impact factor: 4.669

5.  Colonization with extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella species in long-term care facility residents.

Authors:  Ebbing Lautenbach; Jennifer Han; Evelyn Santana; Pam Tolomeo; Warren B Bilker; Joel Maslow
Journal:  Infect Control Hosp Epidemiol       Date:  2012-01-06       Impact factor: 3.254

6.  Activities of NXL104 combinations with ceftazidime and aztreonam against carbapenemase-Producing Enterobacteriaceae.

Authors:  David M Livermore; Shazad Mushtaq; Marina Warner; Jiancheng Zhang; Sunil Maharjan; Michel Doumith; Neil Woodford
Journal:  Antimicrob Agents Chemother       Date:  2010-11-01       Impact factor: 5.191

7.  Point prevalence and risk factors for healthcare-associated infections in primary healthcare wards.

Authors:  T Puhto; P Ylipalosaari; P Ohtonen; H Syrjala
Journal:  Infection       Date:  2011-05-15       Impact factor: 3.553

8.  Healthcare personnel intestinal colonization with multidrug-resistant organisms.

Authors:  B K Decker; A F Lau; J P Dekker; C D Spalding; N Sinaii; S Conlan; D K Henderson; J A Segre; K M Frank; T N Palmore
Journal:  Clin Microbiol Infect       Date:  2017-05-12       Impact factor: 8.067

9.  Flustramine inspired synthesis and biological evaluation of pyrroloindoline triazole amides as novel inhibitors of bacterial biofilms.

Authors:  Cynthia Bunders; John Cavanagh; Christian Melander
Journal:  Org Biomol Chem       Date:  2011-06-15       Impact factor: 3.876

10.  Multidrug-Resistant Microorganisms Colonizing Lower Extremity Wounds in Patients in a Tertiary Care Hospital, Lima, Peru.

Authors:  Rafael Mendo-Lopez; Luis Jasso; Ximena Guevara; Aurora Lizeth Astocondor; Saul Alejos; Ana C Bardossy; Tyler Prentiss; Marcus J Zervos; Jan Jacobs; Coralith García
Journal:  Am J Trop Med Hyg       Date:  2017-07-19       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.